Marton Laurence bought RNXT

March 20, 2026 · Form 4 insider transaction

Marton Laurence bought 4,860 shares of RenovoRx, Inc., a transaction worth N/A. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
4,860
Price
N/A
Total value
N/A
RoleDirector
SecurityWarrants
Transaction codeP: Open-market purchase
Transaction dateMarch 20, 2026
Filing dateMarch 24, 2026
Shares owned after4,860
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

The securities were purchased in a private placement on March 20, 2026 for an aggregate of $10,000.; The warrants are exercisable immediately upon issuance and expire on the earlier of (i) March 30, 2029 or (ii) 30 days following the date the Issuer reports at least $1.5 million in product sales revenue (excluding licensing fees, upfront milestones and grants, but including royalty revenue from product sales) for any calendar quarter in a quarterly or annual report.

View the original Form 4 on SEC EDGAR